|
|
|
|
| LEADER |
00000cam a2200000Ii 4500 |
| 001 |
SCIDIR_on1328563399 |
| 003 |
OCoLC |
| 005 |
20231120010649.0 |
| 006 |
m o d |
| 007 |
cr cnu|||||||| |
| 008 |
220530s2022 ne o 001 0 eng d |
| 040 |
|
|
|a RBN
|b eng
|e rda
|e pn
|c RBN
|d OPELS
|d YDX
|d EBLCP
|d N$T
|d SFB
|d OCLCF
|d OCLCQ
|d OCLCO
|
| 019 |
|
|
|a 1321785117
|a 1323254102
|
| 020 |
|
|
|a 9780323851787
|q (electronic bk.)
|
| 020 |
|
|
|a 0323851789
|q (electronic bk.)
|
| 020 |
|
|
|z 9780323851565
|
| 020 |
|
|
|z 0323851568
|
| 035 |
|
|
|a (OCoLC)1328563399
|z (OCoLC)1321785117
|z (OCoLC)1323254102
|
| 050 |
|
4 |
|a RA644.C67
|
| 082 |
0 |
4 |
|a 616.2414
|
| 100 |
1 |
|
|a Egbuna, Chukwuebuka.
|
| 245 |
0 |
0 |
|a Coronavirus drug discovery :
|b SARS-CoV-2 (Covid 19) prevention, diagnosis, and treatment.
|n Volume 1 /
|c edited by Chukwuebuka Egbuna.
|
| 264 |
|
1 |
|a Amsterdam :
|b Elsevier,
|c 2022.
|
| 264 |
|
4 |
|c �2022.
|
| 300 |
|
|
|a 1 online resource (390 pages)
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 500 |
|
|
|a Includes index.
|
| 588 |
0 |
|
|a Print version record.
|
| 650 |
|
0 |
|a COVID-19 (Disease)
|x Chemotherapy
|x Research.
|
| 650 |
|
0 |
|a COVID-19 (Disease)
|x Diagnosis.
|
| 650 |
|
0 |
|a COVID-19 (Disease)
|x Prevention.
|
| 650 |
|
6 |
|a COVID-19
|0 (CaQQLa)000313216
|x Chimioth�erapie
|0 (CaQQLa)201-0379519
|x Recherche.
|0 (CaQQLa)201-0379425
|
| 650 |
|
7 |
|a COVID-19 (Disease)
|x Diagnosis
|2 fast
|0 (OCoLC)fst01984644
|
| 650 |
|
7 |
|a COVID-19 (Disease)
|x Prevention
|2 fast
|0 (OCoLC)fst02021842
|
| 776 |
0 |
8 |
|i Print version:
|a Egbuna, Chukwuebuka
|t Coronavirus Drug Discovery
|d San Diego : Elsevier,c2022
|z 9780323851565
|
| 776 |
0 |
8 |
|i Print version:
|t Coronavirus drug discovery
|z 9780323851565
|w (OCoLC)1242773891
|
| 856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780323851565
|z Texto completo
|
